Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minodronic acid vs alendronate in postmenopausal osteoporosis
CTR20131018Phase 2Completed
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minodronic acid in osteoporosis, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Sep 2016; status: completed.
02
Drugs
minodronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20131018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131018.